November 29, 2007
MetaCure(TM) Launches Investigational Study Of Gastric Stimulator For Patients With Type 2 Diabetes Who Are Overweight
ADVERTISEMENTS
MetaCure Limited, announced that it began patient enrollment in a national diabetes clinical trial of its TANTALUS(R) System, an investigational device being tested in patients with type 2 diabetes who are overweight. The study is being conducted in up to 30 sites in the United States. The 300-patient trial will evaluate the TANTALUS, an implantable device that delivers electrical pulses to the stomach when a person eats. [click link for full article]










Leave a Comment